Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5951365 | Atherosclerosis | 2010 | 6 Pages |
Abstract
Only a small proportion of patients with heFH reaches the LDL-c treatment target of <2.5Â mmol/l. These results emphasize the need for better monitoring, better utilization of available medication and for new treatment options in heFH to further decrease LDL-c levels.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
A.H. Pijlman, R. Huijgen, S.N. Verhagen, B.P.M. Imholz, A.H. Liem, J.J.P. Kastelein, E.J. Abbink, A.F.H. Stalenhoef, F.L.J. Visseren,